You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR RAZADYNE ER


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for RAZADYNE ER

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00227994 ↗ Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke Completed National Institute of Mental Health (NIMH) Phase 4 2003-04-01 This study will evaluate the effectiveness of treatment with acetylcholinesterase inhibitors in improving cognitive function and overall rehabilitation in elderly stroke survivors.
NCT00227994 ↗ Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke Completed University of Pittsburgh Phase 4 2003-04-01 This study will evaluate the effectiveness of treatment with acetylcholinesterase inhibitors in improving cognitive function and overall rehabilitation in elderly stroke survivors.
NCT00232349 ↗ Efficacy of Galantamine to Treat Schizophrenia Terminated Seattle Institute for Biomedical and Clinical Research Phase 4 2005-02-01 The purpose of this study was to determine if treatment with adjunctive galantamine is effective in the reduction of functional impairments in patients with schizophrenia and schizoaffective disorder. It was hypothesized that adjunctive galantamine would yield clinically significant improvements from baseline to end of study on a measure of quality of life and a measure of independent living skills.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for RAZADYNE ER

Condition Name

Condition Name for RAZADYNE ER
Intervention Trials
Schizophrenia 4
Alzheimer's Disease 4
Tobacco Use Disorder 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for RAZADYNE ER
Intervention Trials
Alzheimer Disease 5
Schizophrenia 4
Tobacco Use Disorder 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for RAZADYNE ER

Trials by Country

Trials by Country for RAZADYNE ER
Location Trials
United States 45
Germany 7
Canada 6
Australia 5
United Kingdom 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for RAZADYNE ER
Location Trials
Pennsylvania 5
Tennessee 4
North Carolina 3
Massachusetts 3
Connecticut 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for RAZADYNE ER

Clinical Trial Phase

Clinical Trial Phase for RAZADYNE ER
Clinical Trial Phase Trials
Phase 4 4
Phase 3 2
Phase 2 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for RAZADYNE ER
Clinical Trial Phase Trials
Completed 13
Terminated 5
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RAZADYNE ER

Sponsor Name

Sponsor Name for RAZADYNE ER
Sponsor Trials
Vanderbilt University Medical Center 4
National Institute on Drug Abuse (NIDA) 3
National Institute of Mental Health (NIMH) 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for RAZADYNE ER
Sponsor Trials
Other 23
NIH 12
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.